Table 7 The association of total AMSTAR-score and selected general characteristics [median (IQR)].
Category | Overall score | AMSTAR-score | Statistic | P-value |
---|---|---|---|---|
8.00 (6.00, 8.25) | ||||
Year of publication | 1.194 | 0.232 | ||
2006~2013 (n = 58) | 7.00(5.00, 9.00) | |||
2014~2015 (n = 44) | 8.00(6.25, 8.00) | |||
Country of corresponding author I | 2.557 | 0.465 | ||
East Asia (n = 34) | 8.00(7.00, 9.00) | |||
Europe (n = 47) | 7.00(5.00, 8.00) | |||
North America (n = 18) | 7.00(5.00, 8.25) | |||
Others (n = 3) | 7.00(6.00, 7.00) | |||
Country of corresponding author II | 2.272 | 0.023 | ||
China (n = 29) | 8.00(7.00, 9.00) | |||
Others (n = 73) | 7.00(5.00, 8.00) | |||
Impact factors of SCI | 5.503 | 0.239 | ||
Not SCI (n = 15) | 8.00(6.00, 8.00) | |||
0.0–2.0 (n = 6) | 5.00(2.00, 9.00) | |||
2.0–5.0 (n = 49) | 7.00(5.00, 8.00) | |||
5.0–10.0 (n = 22) | 8.00(6.00, 9.00) | |||
≥10.0 (n = 10) | 7.00(7.00, 9.00) | |||
Funding source | 1.512 | 0.469 | ||
Not report (n = 42) | 8.00(6.00, 9.00) | |||
Unfunded (n = 14) | 7.50(7.00, 8.00) | |||
Funding-supported (n = 46) | 7.00(5.00, 8.25) | |||
Method | 1.601 | 0.109 | ||
Indirect comparison (n = 41) | 7.00(3.50, 8.00) | |||
Bayes (n = 61) | 8.00(6.00, 9.00) | |||
Categories of disease | 5.649 | 0.342 | ||
Non-small cell lung cancer (n = 19) | 8.00(7.00, 9.00) | |||
Breast cancer (n = 12) | 7.00(4.25, 8.00) | |||
Renal cell carcinoma (n = 7) | 6.00(5.00, 8.00) | |||
Colorectal cancer (n = 6) | 7.50(6.00, 10.25) | |||
Gastric cancer (n = 6) | 8.00(7.00, 9.00) | |||
Others (n = 52) | 7.50(5.25, 8.75) |